Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
S&P Global
SPGI
$125B
| $114M | 0.03% |
+345,785
| New | +$117M |
|
452
Moderna
MRNA
$25.4B
| $113M | 0.03% |
1,084,918
+1,068,494
| +6,506% | +$108M |
|
453
Pinduoduo
PDD
$120B
| $113M | 0.03% |
637,806
+460,614
| +260% | +$55.1M |
|
454
Atlassian
TEAM
$42.1B
| $113M | 0.03% |
484,208
+68,680
| +17% | +$14.5M |
|
455
Vertiv
VRT
$111B
| $113M | 0.03% |
6,061,204
+4,472,265
| +281% | +$82.3M |
|
|
BKI
456
DELISTED
Black Knight, Inc. Common Stock
BKI
| $113M | 0.03% |
1,278,967
+365,865
| +40% | +$33.2M |
|
457
PUT
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $113M | 0.03% |
1,304,500
-256,300
| -16% | -$22.1M |
|
458
PUT
Snowflake
SNOW
$117B
| $113M | 0.03% |
400,200
+187,300
| +88% | +$53.3M |
|
459
Baidu
BIDU
$35.5B
| $112M | 0.03% |
520,074
+289,679
| +126% | +$43M |
|
|
BNY
460
Bank of New York Mellon
BNY
$110B
| $112M | 0.03% |
2,644,745
+1,013,450
| +62% | +$38.9M |
|
461
Teleflex
TFX
$5.82B
| $112M | 0.03% |
272,591
-277,279
| -50% | -$102M |
|
462
CALL
American Tower
AMT
$81.2B
| $112M | 0.03% |
498,900
+120,900
| +32% | +$28.1M |
|
463
PayPal
PYPL
$51.8B
| $112M | 0.03% |
477,364
+255,596
| +115% | +$53M |
|
464
PUT
Zillow
Z
$8.08B
| $112M | 0.03% |
861,200
+290,800
| +51% | +$32.2M |
|
465
CALL
Amgen
AMGN
$226B
| $112M | 0.03% |
485,000
-55,300
| -10% | -$12.7M |
|
466
PUT
Carvana
CVNA
$81B
| $112M | 0.03% |
2,327,500
-476,500
| -17% | -$21.8M |
|
467
CALL
ASML
ASML
$710B
| $111M | 0.03% |
228,400
+60,900
| +36% | +$25.6M |
|
468
Qualcomm
QCOM
$173B
| $111M | 0.03% |
730,414
-361,394
| -33% | -$50.3M |
|
469
United Therapeutics
UTHR
$21.5B
| $111M | 0.03% |
732,008
+103,306
| +16% | +$13.6M |
|
470
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $111M | 0.03% |
1,896,100
+406,000
| +27% | +$20.6M |
|
471
Valero Energy
VLO
$98.7B
| $111M | 0.03% |
1,959,484
+669,994
| +52% | +$32.9M |
|
|
CONE
472
DELISTED
CyrusOne Inc Common Stock
CONE
| $111M | 0.03% |
1,512,892
-656,150
| -30% | -$47.6M |
|
473
Vulcan Materials
VMC
$36B
| $111M | 0.03% |
746,157
+477,418
| +178% | +$68.1M |
|
474
PUT
Las Vegas Sands
LVS
$29.6B
| $110M | 0.03% |
1,852,900
-6,000
| -0.3% | -$320K |
|
475
Neurocrine Biosciences
NBIX
$15.3B
| $110M | 0.03% |
1,147,507
+836,009
| +268% | +$80.7M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.